Details for Patent: 6,214,865
✉ Email this page to a colleague
Which drugs does patent 6,214,865 protect, and when does it expire?
Patent 6,214,865 protects HALAVEN and is included in one NDA.
Protection for HALAVEN has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has forty patent family members in twenty-one countries.
Summary for Patent: 6,214,865
| Title: | Macrocyclic analogs and methods of their use and preparation |
| Abstract: | The invention provides halichondrin analogs having pharmaceutical activity, such as anticancer or antimitotic (mitosis-blocking) activity, and methods of identifying agents that induce a sustained mitotic block in a cell after transient exposure of the cell to the agents. |
| Inventor(s): | Littlefield; Bruce A. (Andover, MA), Palme; Monica H. (San Jose, CA), Seletsky; Boris M. (Andover, MA), Towle; Murray J. (Auburn, NH), Yu; Melvin J. (Andover, MA), Zheng; Wanjun (Londonberry, NH) |
| Assignee: | Eisai Co., Ltd. (Tokyo, JP) |
| Application Number: | 09/334,488 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 6,214,865 |
|
Patent Claim Types: see list of patent claims | Compound; Use; |
More… ↓ |
Drugs Protected by US Patent 6,214,865
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eisai Inc | HALAVEN | eribulin mesylate | SOLUTION;INTRAVENOUS | 201532-001 | Nov 15, 2010 | AP | RX | Yes | Yes | 6,214,865*PED | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,214,865
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1087960 | ⤷ Subscribe | C300493 | Netherlands | ⤷ Subscribe |
| European Patent Office | 1087960 | ⤷ Subscribe | 91854 | Luxembourg | ⤷ Subscribe |
| European Patent Office | 1087960 | ⤷ Subscribe | CA 2011 00022 | Denmark | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
